Manhattan Scientifics, Inc. (MHTX)

[Hncher]

Reading all of the publications that Proulx has put out, including this last one, it is clear that "clinical instrument design plan is complete" the "design" may be complete, but I doubt that the human instrument is complete and ready.

My guess and only a guess is no, the human instrument is far from complete and the first study (lymph node biopsies) will be done using that old instrument that resides at MD Anderson.

It is the only logical step considering Imagion's financial status.

Think about it for just one minute, how much time and $$$ IBX would have to invest to build the new human instrument, create the tests for the studies, etc. Not happening this quarter unless there is a large influx of funds, which of course will mean more dilution.

As par for the course, Proulx has not made this clear and has everyone, including all of us here trying to look for breadcrumbs and answers.

To our mate Rusty, hey, nice find on the new $2M Aussie bucks "similar tax refund of approximately $2 million, which it expects to receive in the second calendar quarter of 2020"

I guess I can B & complain, but not going to I am done with that. Patience is part of the game with this stock.